iCAD, Inc. (NASDAQ:ICAD) Q4 2024 Earnings Call Transcript
Operator: Greetings. Welcome to the iCAD Inc. Fourth Quarter and Full Year 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Icad Inc (ICAD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 919,372 | $1,893,904 | 0.01% | |
| 2. | Parkman Healthcare Partners Greg Martinez | 781,670 | $1,610,240 | 0.19% | |
| 3. | First Eagle Investment Management Jean-Marie Eveillard | 724,519 | $1,492,509 | +2% | 0% |
| 4. | Renaissance Technologies Jim Simons | 655,990 | $1,351,339 | +38% | 0% |
| 5. | Citadel Investment Group Ken Griffin | 232,713 | $479,389 | +439% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.30 | 40,000 | $52,000.00 | 40,000 | 2023-03-31 | Filing | |
| $4.63 | 5,500 | $25,465.00 | 5,500 | 2022-03-03 | Filing | |
| $6.17 | 17,006 | $104,927.02 | 154,627 | 2022-01-05 | Filing | |
| $7.05 | 7,000 | $49,350.00 | 7,000 | 2021-12-08 | Filing | |
| $7.24 | 6,900 | $49,956.00 | 183,947 | 2021-12-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.65 | 1,080 | $2,862.00 | 188,725 | 2022-09-12 | Filing | |
| $2.74 | 37,880 | $103,791.20 | 189,805 | 2022-09-12 | Filing | |
| $5.49 | 10,000 | $54,900.00 | 1,198,382 | 2022-02-08 | Filing | |
| $5.26 | 10,000 | $52,600.00 | 1,208,382 | 2022-02-07 | Filing | |
| $6.07 | 10,000 | $60,700.00 | 1,218,382 | 2022-01-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,209,545 | $2,491,663 | 0% | |
| 2. | 352,330 | $725,800 | 0% | |
| 3. | 288,078 | $593,441 | 0.1% | |
| 4. | 286,289 | $589,912 | 0% | |
| 5. | 245,033 | $504,768 | 0% |
News See All
18 AI News and Ratings Making Waves on Wall Street
In a recent discussion at CNBC's 'Squawk on the Street', NYU professor and AI expert, Gary Marcus shared his perspective on the limitations of current AI models, the hurdles in enterprise adoption, and...
iCAD, Inc. (ICAD): A Bull Case Theory
We came across a bullish thesis on iCAD, Inc. (ICAD) on Twitter by northeasternsvf. In this article, we will summarize the bulls’ thesis on ICAD. iCAD, Inc.
9 AI News and Ratings on Wall Street's Radar
AI is transforming industries by enabling machines to learn, adapt, and make decisions based on data.
Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025
The healthcare sector is staging a comeback so far in 2025 after two years of underperformance. These stocks could get even hotter due to AI.
Why ICAD Stock Is Climbing Today
iCAD (ICAD) is advancing 5% in early trading despite today's sharp downturn of the broader market.
Why Drug Developers That Utilize AI, Including SDGR and RXRX, Are Jumping
Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.
iCAD, Inc. (NASDAQ:ICAD) Q3 2024 Earnings Call Transcript
Operator: Greetings. Welcome to the iCAD Incorporated Third Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
ICAD, Inc. (ICAD): A Bull Case Theory
We came across a bullish thesis on ICAD, Inc. (ICAD) on Multibagger Monitor’s Substack by Multibagger Monitor. In this article, we will summarize the bulls’ thesis on ICAD.
iCAD, Inc. (NASDAQ:ICAD) Q2 2024 Earnings Call Transcript
Operator: Good day and welcome to the iCAD Incorporated Second Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
